Mastoparan | List of Frontiers open access articles

Original Research

Published on 29 May 2025

Studies on the antibacterial activity of the antimicrobial peptide Mastoparan X against methicillin-resistant Staphylococcus aureus

in Antibiotic Resistance and New Antimicrobial drugs

Zhangping Lu
Xiaofang Liang
Wenbo Deng
Qianqian Liu
Yulin Wang
Meng Liu
Fugui Lin
Zhihong Liu
Yu Zhang
Wenjie Wang

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1552872

4,610 views
3 citations

Original Research

Published on 21 Feb 2020

Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide

in Antimicrobials, Resistance and Chemotherapy

Sándor Jenei
Hilda Tiricz
János Szolomájer
Edit Tímár
Éva Klement
Mohamad Anas Al Bouni
Rui M. Lima
Diána Kata
Mária Harmati
Krisztina Buzás

Frontiers in Microbiology

doi 10.3389/fmicb.2020.00270

9,906 views
33 citations

Original Research

Published on 06 Dec 2019

Antifungal Activity, Toxicity, and Membranolytic Action of a Mastoparan Analog Peptide

in Fungal Pathogenesis

Junya de Lacorte Singulani
Mariana Cristina Galeane
Marina Dorisse Ramos
Paulo César Gomes
Claudia Tavares dos Santos
Bibiana Monson de Souza
Mario Sergio Palma
Ana Marisa Fusco Almeida
Maria José Soares Mendes Giannini

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2019.00419

16,031 views
33 citations

Original Research

Published on 10 Sep 2021

Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens

in Vaccines and Molecular Therapeutics

Brandi T. Johnson-Weaver
Hae Woong Choi
Hang Yang
Josh A. Granek
Cliburn Chan
Soman N. Abraham
Herman F. Staats

Frontiers in Immunology

doi 10.3389/fimmu.2021.730346

5,734 views
14 citations

Original Research

Published on 10 Jun 2021

The Antimicrobial Peptide Mastoparan X Protects Against Enterohemorrhagic Escherichia coli O157:H7 Infection, Inhibits Inflammation, and Enhances the Intestinal Epithelial Barrier

in Antimicrobials, Resistance and Chemotherapy

Xueqin Zhao
Lei Wang
Chunling Zhu
Xiaojing Xia
Shouping Zhang
Yimin Wang
Huihui Zhang
Yanzhao Xu
Shijun Chen
Jinqing Jiang

Frontiers in Microbiology

doi 10.3389/fmicb.2021.644887

7,255 views
25 citations

Brief Research Report

Published on 18 Jul 2023

Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study

in Pharmacology of Infectious Diseases

Kai Hilpert
Christoph Rumancev
Jurnorain Gani
Dominic W. P. Collis
Paula Matilde Lopez-Perez
Vasil M. Garamus
Ralf Mikut
Axel Rosenhahn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141785

2,796 views
1 citation

Articles

Studies on the antibacterial activity of the antimicrobial peptide Mastoparan X against methicillin-resistant Staphylococcus aureus

Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide

Antifungal Activity, Toxicity, and Membranolytic Action of a Mastoparan Analog Peptide

Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens

The Antimicrobial Peptide Mastoparan X Protects Against Enterohemorrhagic Escherichia coli O157:H7 Infection, Inhibits Inflammation, and Enhances the Intestinal Epithelial Barrier

Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study